Insiders Trades
AIAIグループ(株) Stock: price and insider trades · Japan
AIAIグループ(株): what insiders have been doing
Only a handful of insider records exist for AIAIグループ(株), the last one from 23 March 2023, too few to describe a trend. Source: insider filings from EDINET (Japan FSA). Past trades are no guide to future returns.
Insider Decl.
2
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 9,881 of 24,148 companies
56.2
score / 100
Value72
Quality41
FCF yld12%
Earn yld13%
EV/EBITDA14.7x
ROE20%
Gross mgn19%
Net mgn4.2%
Debt/EBITDA11.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
JP¥726
Analyst consensus
Income statement
RevenueJP¥14.6B
Gross profitJP¥2.8B19% margin
EBITDAJP¥1.6B11% margin
Net incomeJP¥621.6M4.2% margin
Valuation
PER (trailing)7.6x
P/Book1.4x
Beta0.43
Balance sheet & cash
Market capJP¥4.7B
Total debtJP¥19.5B
Free Cash FlowJP¥584.9M
Debt / Equity602%
Profitability & ownership
ROE20.5%
ROA3.5%
% insiders66.8%
% institutions0.6%
Last declaration on 23 March 2023
About AIAIグループ(株)
AIAI Group Inc. is a Japanese company operating in the healthcare and pharmaceutical sector. It is listed on the XTKS market.